SI
Sofinnova Investments Portfolio holdings
AUM
$1.47B
1-Year Return
17.43%
This Quarter Return
+0.89%
1 Year Return
+17.43%
3 Year Return
+337.79%
5 Year Return
+424.38%
10 Year Return
–
AUM
$1.06B
AUM Growth
+$48K
(+0%)
Cap. Flow
+$72.8M
Cap. Flow
% of AUM
6.9%
Top 10 Holdings %
Top 10 Hldgs %
58.8%
Holding
82
New
15
Increased
23
Reduced
6
Closed
12
Top Buys
| 1 |
Amgen
AMGN
|
$17.9M |
| 2 |
United Therapeutics
UTHR
|
$15.5M |
| 3 |
Bristol-Myers Squibb
BMY
|
$15.4M |
| 4 |
Pfizer
PFE
|
$14.8M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
$12.1M |
Top Sells
| 1 |
PRNB
Principia Biopharma Inc. Common Stock
PRNB
|
$17.5M |
| 2 |
Novo Nordisk
NVO
|
$16.5M |
| 3 |
Heron Therapeutics
HRTX
|
$9.5M |
| 4 |
Incyte
INCY
|
$5.91M |
| 5 |
Acadia Pharmaceuticals
ACAD
|
$4.16M |
Sector Composition
| 1 | Healthcare | 91.74% |